PhOx430

· Phost'In Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PhOx430, covering 2025-04-08 to 2025-04-08. Get the full timeline:

Most recent: Clinical Trial Update: First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours [Phase 1]

See pricing